Gero Knittel

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

CSNK1E as a key to unlocking drug persistence in DLBCL.

CSNK1E as a key to unlocking drug persistence in DLBCL.

Journal: Blood
Published: May 28, 2026

CLL cell-derived soluble factors do not influence the functionality of normal B cells.

CLL cell-derived soluble factors do not influence the functionality of normal B cells.

Journal: Frontiers in immunology
Published: January 23, 2026

Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

Journal: Blood
Published: January 21, 2026

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Journal: Molecular cancer
Published: September 08, 2025

Eμ-TCL1 mice with conditional human BCL2 knockin as novel B-cell lymphoma model for studying venetoclax effects in vivo.

Eμ-TCL1 mice with conditional human BCL2 knockin as novel B-cell lymphoma model for studying venetoclax effects in vivo.

Journal: Blood neoplasia
Published: March 04, 2025

Genetic Mouse Models of Lymphomas.

Genetic Mouse Models of Lymphomas.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 18, 2024

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell
Published: August 25, 2024

Lymphoma accelerates T cell and tissue aging.

Lymphoma accelerates T cell and tissue aging.

Journal: Cancer cell
Published: February 29, 2024

Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.

Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.

Journal: European journal of haematology
Published: December 30, 2023

XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive Lymphoma.

XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive Lymphoma.

Journal: Cancer research
Published: October 26, 2023

Mouse models of diffuse large B cell lymphoma.

Mouse models of diffuse large B cell lymphoma.

Journal: Frontiers in immunology
Published: October 10, 2023

An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma.

An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma.

Journal: Blood advances
Published: July 14, 2023
Showing 1-12 of 37

Last Updated: 09/26/2026